tirzepatide banned by fda says compounding pharmacies can keep making weight-loss med tirzepatide, for now FDA Ban on Compounded GLP-1

We highly recommend you work with a doctor who is familiar with GLP-1s or GLP-1/GIP combination medication AND understands the intricacies of their use for weight loss

Clinical outcomes after discontinuation of GLP-1 receptor agonists: STEP-1 and SURMOUNT-4

A prespecified analysis of SELECT further suggested reductions in composite HF outcomes among participants with and without prior HF, although these findings were secondary analyses rather than HF-dedicated trial endpoints [17]

Eligible studies were cohort or case-control studies that assessed maternal exposure to GLP-1 receptor agonists from 90 days before conception through the end of pregnancy and included an appropriate unexposed comparator group

doi: 10.1016/j.ejim.2019.03.014 10 ChowEClementSGargR

1-2 Months Berberine Blend (Berberine, Pomegranate, Cinnamon) A botanical blend featuring plant-derived compounds with a long history of traditional use and modern research interest